Interstitial Cystitis (cont.)

Cancer

There is no evidence that PBS/IC increases the risk of bladder cancer; however, the long-term effects of PBS/IC have not been well-studied and require further observation and research.

Pregnancy

Researchers have little information about the relationship between pregnancy and PBS/IC but believe that PBS/IC does not affect fertility or the health of the fetus. Some women have a remission from PBS/IC during pregnancy while others have more pain and pressure during the third trimester, possibly due to the weight of the fetus on the bladder.

Coping with PBS/IC

The emotional support of family, friends, and other individuals with PBS/IC is very important in helping patients cope with PBS/IC. Studies have found that patients with PBS/IC who are educated about PBS/IC and become involved in their own care do better than patients who do not. Support groups for people with interstitial cystitis also have been beneficial for many.

PBS/IC is a chronic condition that is characterized by periods of relapse and remission. Doctors do not fully understand why the symptoms worsen at particular times or disappear and then reappear months or years later. Symptoms may be mild or severe and may vary in intensity even in the same individual over time. There is no cure for PBS/IC, and treatments are directed at reducing the severity of symptoms.

There has been no treatment that has been shown to be effective in slowing the progression of the disease or in preventing recurrences.

• PBS/IC is an inflammatory disease of the bladder that can cause ulceration and bleeding of the bladder's lining and can lead to scarring and stiffening of the bladder.
• The symptoms of PBS/IC are pelvic pain as well as urinary frequency and urgency.
• PBS/IC has a variable clinical course, meaning that symptoms can appear and disappear over time. Moreover, the intensity of symptoms varies among individuals and even within the same individual over time.
• The cause of PBS/IC is unknown, but abnormalities in the leakiness or structure of the lining of the bladder are believed to play a role in the development of PBS/IC.
• The diagnosis of PBS/IC is based on the symptoms, an abnormal potassium sensitivity test (PST), and elimination of other conditions that may be responsible for the symptoms.
• Treatment for PBS/IC most commonly utilizes heparinoid drugs to help restore integrity of the bladder lining along with other oral medications. Bladder distension and intravesical drug therapy are other treatments that may provide relief in PBS/IC.

Additional sources of information about PBS/IC:

Interstitial Cystitis Association of America
110 North Washington Street, Suite 340
Rockville, MD 20850
Phone: 1-800-HELP-ICA (435-7422) or 301-610-5300
Fax: 301-610-5308
Email: icamail@ichelp.org
Internet: http://www.ichelp.org

American Urogynecologic Society
2025 M Street NW., Suite 800
Washington, DC 20036
Phone: 202-367-1167
Fax: 202-367-2167
Email: augs@dc.sba.com
Internet: http://www.augs.org

European Society for the Study of Interstitial Cystitis
http://www.essic.eu

REFERENCES:

Abrams, P., L. Cardozo, M. Fall, et al. "The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society." Neurourol Urodyn 21 (2002): 167.

NIH Publication No. 05-3220 June 2005

van de Merwe, J.P., J. Nordling, P. Bouchelouche, et al. "Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal." Eur Urol 53 (2008): 60.

Last Editorial Review: 11/30/2009

Source: MedicineNet.com
http://www.medicinenet.com/interstitial_cystitis/article.htm